Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Walker

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Plos One|October 23, 2010
The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urineHayley C Whitaker, Zsofia Kote-Jarai, Helen Ross-Adams, et al.
Human Molecular Genetics|November 11, 2011
Gene-gene interactions in breast cancer susceptibilityClare Turnbull, Sheila Seal, Anthony Renwick, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2014
Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected statusKaren A Pooley, Lesley McGuffog, Daniel Barrowdale, et al.
Nature Genetics|August 9, 2011
Germline mutations in RAD51D confer susceptibility to ovarian cancerChey Loveday, Clare Turnbull, Emma Ramsay, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 4, 2019
Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort ConsortiumHongyan Li, Mary Beth Terry, Antonis C Antoniou, et al.
Nature|December 18, 2012
Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancerElise Ruark, Katie Snape, Peter Humburg, et al.
JNCI Cancer Spectrum|July 31, 2019
Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort StudyLieske H Schrijver, Håkan Olsson, Kelly-Anne Phillips, et al.
British Journal of Cancer|January 5, 2018
Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predispositionChristos Mikropoulos, Christina G Hutten Selkirk, Sibel Saya, et al.
European Urology|February 4, 2014
Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT studyElizabeth K Bancroft, Elizabeth C Page, Elena Castro, et al.
British Journal of Cancer|March 7, 2018
Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predispositionChristos Mikropoulos, Christina G Hutten Selkirk, Sibel Saya, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Plos One|October 23, 2010
The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urineHayley C Whitaker, Zsofia Kote-Jarai, Helen Ross-Adams, et al.
Human Molecular Genetics|November 11, 2011
Gene-gene interactions in breast cancer susceptibilityClare Turnbull, Sheila Seal, Anthony Renwick, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2014
Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected statusKaren A Pooley, Lesley McGuffog, Daniel Barrowdale, et al.
Nature Genetics|August 9, 2011
Germline mutations in RAD51D confer susceptibility to ovarian cancerChey Loveday, Clare Turnbull, Emma Ramsay, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 4, 2019
Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort ConsortiumHongyan Li, Mary Beth Terry, Antonis C Antoniou, et al.
Nature|December 18, 2012
Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancerElise Ruark, Katie Snape, Peter Humburg, et al.
JNCI Cancer Spectrum|July 31, 2019
Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort StudyLieske H Schrijver, Håkan Olsson, Kelly-Anne Phillips, et al.
British Journal of Cancer|January 5, 2018
Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predispositionChristos Mikropoulos, Christina G Hutten Selkirk, Sibel Saya, et al.
European Urology|February 4, 2014
Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT studyElizabeth K Bancroft, Elizabeth C Page, Elena Castro, et al.
British Journal of Cancer|March 7, 2018
Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predispositionChristos Mikropoulos, Christina G Hutten Selkirk, Sibel Saya, et al.
Pageof 9